Upgrade to SI Premium - Free Trial

Jazz Pharmaceuticals (JAZZ) PT Raised to $300 at Deutsche Bank

August 26, 2026 3:09 AM
Deutsche Bank analyst David Hoang raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $300.00 (from $287.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change